U.S. Antibody Drug Conjugates Market: Transforming Cancer Care with Smarter Drugs

The U.S. antibody drug conjugates (ADC) market is witnessing remarkable growth, driven by the rising prevalence of cancer, technological advancements in biotechnology, and increasing investments in targeted therapies. ADCs are innovative therapeutics...